BioCorRx Inc. (BICX)
USD 0.43
(-14.0%)
USD 0.43
(-14.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.34 Million USD | 15.31% |
| 2022 | 8.96 Million USD | 15.25% |
| 2021 | 7.78 Million USD | 28.89% |
| 2020 | 6.03 Million USD | 20.94% |
| 2019 | 4.99 Million USD | -21.19% |
| 2018 | 6.33 Million USD | 49.69% |
| 2017 | 4.23 Million USD | -50.8% |
| 2016 | 8.6 Million USD | 83.46% |
| 2015 | 4.68 Million USD | 24.12% |
| 2014 | 3.77 Million USD | -10.14% |
| 2013 | 4.2 Million USD | 87.12% |
| 2012 | 2.24 Million USD | 119.28% |
| 2011 | 1.02 Million USD | 5271.87% |
| 2010 | 19.06 Thousand USD | 70.22% |
| 2009 | 11.2 Thousand USD | 244.15% |
| 2008 | 3255.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 11.62 Million USD | 3.94% |
| 2024 Q1 | 11.18 Million USD | 8.16% |
| 2023 Q1 | 9.53 Million USD | 6.33% |
| 2023 Q3 | 9.79 Million USD | 3.46% |
| 2023 FY | 10.34 Million USD | 15.31% |
| 2023 Q4 | 10.34 Million USD | 5.58% |
| 2023 Q2 | 9.46 Million USD | -0.72% |
| 2022 Q1 | 7.89 Million USD | 1.5% |
| 2022 Q3 | 8.01 Million USD | -3.97% |
| 2022 Q2 | 8.35 Million USD | 5.74% |
| 2022 FY | 8.96 Million USD | 15.25% |
| 2022 Q4 | 8.96 Million USD | 11.83% |
| 2021 FY | 7.78 Million USD | 28.89% |
| 2021 Q4 | 7.78 Million USD | 5.32% |
| 2021 Q3 | 7.38 Million USD | 21.55% |
| 2021 Q2 | 6.07 Million USD | -3.42% |
| 2021 Q1 | 6.29 Million USD | 4.25% |
| 2020 Q2 | 6.22 Million USD | -2.43% |
| 2020 Q3 | 5.84 Million USD | -6.15% |
| 2020 FY | 6.03 Million USD | 20.94% |
| 2020 Q4 | 6.03 Million USD | 3.31% |
| 2020 Q1 | 6.38 Million USD | 27.85% |
| 2019 Q1 | 6.85 Million USD | 8.2% |
| 2019 Q4 | 4.99 Million USD | 11.36% |
| 2019 Q3 | 4.48 Million USD | -48.22% |
| 2019 Q2 | 8.65 Million USD | 26.32% |
| 2019 FY | 4.99 Million USD | -21.19% |
| 2018 Q4 | 6.33 Million USD | 16.86% |
| 2018 Q2 | 4.93 Million USD | 5.43% |
| 2018 Q1 | 4.67 Million USD | 10.57% |
| 2018 FY | 6.33 Million USD | 49.69% |
| 2018 Q3 | 5.42 Million USD | 9.89% |
| 2017 Q2 | 2.95 Million USD | -93.6% |
| 2017 Q3 | 3.28 Million USD | 11.4% |
| 2017 Q4 | 4.23 Million USD | 28.77% |
| 2017 FY | 4.23 Million USD | -50.8% |
| 2017 Q1 | 46.11 Million USD | 436.2% |
| 2016 Q2 | 6.1 Million USD | 56.71% |
| 2016 Q3 | 7.57 Million USD | 24.2% |
| 2016 FY | 8.6 Million USD | 83.46% |
| 2016 Q4 | 8.6 Million USD | 13.51% |
| 2016 Q1 | 3.89 Million USD | -16.96% |
| 2015 Q1 | 3.87 Million USD | 2.56% |
| 2015 Q2 | 4.94 Million USD | 27.77% |
| 2015 Q3 | 4.99 Million USD | 0.86% |
| 2015 Q4 | 4.68 Million USD | -6.09% |
| 2015 FY | 4.68 Million USD | 24.12% |
| 2014 Q2 | 4.46 Million USD | -12.44% |
| 2014 Q1 | 5.09 Million USD | 21.23% |
| 2014 Q3 | 3.86 Million USD | -13.27% |
| 2014 Q4 | 3.77 Million USD | -2.4% |
| 2014 FY | 3.77 Million USD | -10.14% |
| 2013 Q1 | 2.61 Million USD | 16.28% |
| 2013 Q3 | 3.05 Million USD | 3.78% |
| 2013 Q4 | 4.2 Million USD | 37.6% |
| 2013 FY | 4.2 Million USD | 87.12% |
| 2013 Q2 | 2.94 Million USD | 12.7% |
| 2012 Q2 | 1.96 Million USD | 39.34% |
| 2012 FY | 2.24 Million USD | 119.28% |
| 2012 Q4 | 2.24 Million USD | 14.33% |
| 2012 Q1 | 1.4 Million USD | 37.34% |
| 2012 Q3 | 1.96 Million USD | 0.23% |
| 2011 Q1 | 29.06 Thousand USD | 52.44% |
| 2011 Q3 | 38.29 Thousand USD | 7.28% |
| 2011 Q2 | 35.69 Thousand USD | 22.79% |
| 2011 FY | 1.02 Million USD | 5271.87% |
| 2011 Q4 | 1.02 Million USD | 2574.86% |
| 2010 Q1 | 11.97 Thousand USD | 6.91% |
| 2010 Q3 | 18.38 Thousand USD | 13.77% |
| 2010 Q4 | 19.06 Thousand USD | 3.69% |
| 2010 FY | 19.06 Thousand USD | 70.22% |
| 2010 Q2 | 16.16 Thousand USD | 34.97% |
| 2009 Q2 | 8550.00 USD | 21.28% |
| 2009 Q1 | 7050.00 USD | 116.59% |
| 2009 FY | 11.2 Thousand USD | 244.15% |
| 2009 Q4 | 11.2 Thousand USD | 24.47% |
| 2009 Q3 | 9000.00 USD | 5.26% |
| 2008 FY | 3255.00 USD | 0.0% |
| 2008 Q1 | 7050.00 USD | 0.0% |
| 2008 Q4 | 3255.00 USD | 5.85% |
| 2008 Q3 | 3075.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | 58.148% |
| Arem Pacific Corporation | 304.9 Thousand USD | -3291.705% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -5515.236% |
| Bionik Laboratories Corp. | 5 Million USD | -106.716% |
| Banyan Corp. | 4.51 Million USD | -128.872% |
| Clearday, Inc. | 65.13 Million USD | 84.122% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -473.853% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -687484.673% |
| Empower Clinics Inc. | 9.18 Million USD | -12.581% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | 67.329% |
| Selectis Health, Inc. | 43.63 Million USD | 76.3% |
| Ethema Health Corporation | 17.71 Million USD | 41.638% |
| HealthLynked Corp. | 3.47 Million USD | -197.559% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | 28.556% |
| JRSIS Health Care Corporation | 2.3 Million USD | -348.617% |
| Comjoyful International Company | 6.32 Million USD | -63.472% |
| Medical Facilities Corporation | 235.37 Million USD | 95.606% |
| MedSmart Group Inc. | 927.53 Thousand USD | -1014.94% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -1003.849% |
| Nova Leap Health Corp. | 2.69 Million USD | -283.163% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -258.811% |
| PAO Group, Inc. | 1.04 Million USD | -888.132% |
| Primemd Inc. | 7.98 Million USD | -29.451% |
| Raffles Medical Group Ltd | 367.04 Million USD | 97.183% |
| Ryman Healthcare Limited | 5.17 Billion USD | 99.8% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -12742.485% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -164.093% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -143.458% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -1429.795% |
| Veltex Corporation | 2.87 Million USD | -259.421% |
| World Financial Holding Group | 132.5 Thousand USD | -7704.544% |
| Xcelerate Inc. | 2.07 Million USD | -398.244% |